| |
Medical
Device Labeling Translation Subject of Crimson Life Sciences Study
Crimson Life Sciences has completed a two year study of translation of medical device labeling. According to the findings, the average “serious error rate” in labeling translation was 400% higher than the serious error rate associated with the current industry best practice. To learn more about the Crimson study, please click here.
|